Skip to content
TrackPodcasts
artsJul 3, 202512:57pending

How Targeted Therapy Is Revolutionizing Lung Cancer Treatment: What Every Patient Should Know

About this episode

In this episode, we explore how targeted therapy is changing the way doctors treat lung cancer, especially for patients with non-small cell lung cancer (NSCLC) and specific gene mutations like EGFR and ALK.

You’ll learn:

  • What targeted therapy is and how it differs from chemotherapy
  • Why is it more precise and causes fewer side effects
  • How doctors match treatments to your cancer’s gene profile
  • The role of tyrosine kinase inhibitors (TKIs) and monoclonal antibodies
  • Common side effects to watch for and how they’re managed
  • How targeted therapy can be combined with other treatments for better results
  • What you can do to stay involved and improve your treatment outcomes

Whether you’re newly diagnosed or exploring your next step after chemo, this episode gives you a clear, hopeful look at how targeted therapy works—and why it could be the breakthrough you’ve been waiting for.

Blog Link: Targeted Therapy for Lung Cancer

Send us Fan Mail

Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.

Author: Dr. CHRISTINA NG VAN TZE

📍 Visit us at oncolifecentre.com
📞 Call: +60 3 2242 3260
📧 Book a consultation or ask a question — we're here to support your journey.

Get every episode summarized

Each time The Onco Life Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

How Targeted Therapy Is Revolutionizing Lung Cancer Treatment: What Every Patient Should Know

The Onco Life Podcast

0:00
12:57

More episodes

More from The Onco Life Podcast

View all episodes →